Pattern of and survival following loco-regional and distant recurrence in patients with HPV+ and HPV − oropharyngeal squamous cell carcinoma: A population-based study
The incidence of patients diagnosed with human papillomavirus positive (HPV+) oropharyngeal squamous cell carcinoma (OPSCC) is increasing. Nevertheless, this OPSCC group has a markedly better prognosis compared with the tobacco-related (HPV −) OPSCCs [1–3]. Regardless, up to 25% of patients with HPV+ OPSCC encounter disease recurrence within three years of completed treatment [4–6]. The risk of short-term loco-regional failure is reported low for patients with HPV+ or p16+ (a surrogate marker for HPV) tumors compared to patients with HPV or p16 negative tumors.
Source: Oral Oncology - Category: Cancer & Oncology Authors: Christian Gr ønhøj, Kathrine Kronberg Jakobsen, David H. Jensen, Jacob Rasmussen, Elo Andersen, Jeppe Friborg, Christian von Buchwald Source Type: research
More News: Cancer & Oncology | Carcinoma | Genital Warts | Human Papillomavirus (HPV) | Oral Cancer | Oropharyngeal Cancer | Skin Cancer | Smokers | Squamous Cell Carcinoma | Study